1. Development and regulation of biosimilars: current status and future challenges;Tsiftsoglou;BioDrugs,2013
2. Guideline on similar biological medicinal products containing monoclonal antibodies – non-clinical and clinical issues;Committee for Medicinal Products for Human Use, European Medicines Agency,2012
3. Guidance for sponsors: information and submission requirements for subsequent entry biologics (SEBs);Health Products and Food Branch, Health Canada,2010
4. Guidance for industry: scientific considerations in demonstrating biosimilarity to a reference product (draft guidance);U.S. Food and Drug Administration,2012
5. Guidelines on evaluation of similar biotherapeutic products;Expert Committee on Biological Standardization, World Health Organization,2009